Corcept Therapeutics | CORT - 净收入



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 12.87B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


净收入 更改 日
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Alaunos Therapeutics USD -1.01M 153K 2026-03
ANI Pharmaceuticals USD 24.71M 4.78M 2026-06
Ardelyx USD -37.6M 37.2M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Canopy Growth CAD -157.11M 94.49M 2026-03
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
J&J USD 5.53B 299M 2026-06
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Merck USD -1.34B 2.9B 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Novartis USD 3.26B 108M 2026-06
Novartis USD 3.16B 747M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 4.65M 1.74M 2026-06
Pfizer USD -248M 2.94B 2026-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
TG Therapeutics USD 7.78M 12M 2026-06